Investor Presentaiton slide image

Investor Presentaiton

Q4FY22 Q1FY23 Pharmacy Retail Diagnostic Others Total Pharmacy Retail Diagnostic Others Total Operating EBITDA 396.6 -76.0 % % & -25.3 295.2 292.3 -51.9 -18.7 221.7 % % % % % 653.3 % 627.7 % MedPlus+
View entire presentation